ArticleACR open rheumatology2026

Anifrolumab Plus Standard of Care Reduces Long-Term Cardiovascular Damage in Adults With Systemic Lupus Erythematosus: Findings From a Real-World External Control Study.

Zahi Touma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.